BioDuro Completes Divestiture of its Drug Product Manufacturing Facility in Irvine, California
IRVINE, Calif. January 12, 2026 – BioDuro, a leading global contract research, development, and manufacturing organization (CRDMO), today announced the completion of the sale of its Irvine-based drug product facility to Forma Life Sciences, Inc., a Delware entity formed by BioSelective Capital Investments and Shayan Enterprises, LLC, for the purpose of the acquisition.
January 12, 2026